Haemophilia trials in Germany
13 of 29 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationPatient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany
- Where
- Mainz
- Age
- 18 years and over
- People
- 150
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07653139 - Phase 4Taking peopleTreatment of Hemophilia A Patients With FVIII Inhibitors
- Where
- Bonn, Duisburg, Frankfurt am Main, Giessen, Muenster
- People
- 120 worldwide
- Run by
- Emory University
See details and how to joinNCT04023019 · EU 2024-516741-39-00 - No phaseEnrolling by invitationA Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
- Where
- Berlin, Bonn
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03745924 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Berlin, Bonn, Duisburg, Essen, Frankfurt
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - No phaseTaking peopleA Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
- Where
- Frankfurt am Main
- People
- 300
- Run by
- Haemophilia Centre Rhine Main
See details and how to joinNCT02207894 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Berlin, Bonn, Frankfurt, Hanover
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - Phase 4Enrolling by invitationA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Berlin, Bonn
- Age
- 18 years and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - No phaseEnrolling by invitationA Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
- Where
- Berlin, Bonn
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT04574076 - No phaseTaking peopleThe European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Berlin, Bonn, Bremen, Frankfurt, Frankfurt am Main, Munich
- People
- 4,000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119 - Phase 2/3Enrolling by invitationLong-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
- Where
- Berlin
- Age
- 18 years and over
- People
- 56 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00 - No phaseTaking peoplePrevalence of Synovitis in Patients With Haemophilia A
- Where
- Bonn
- Age
- 18 years and over
- People
- 300
- Run by
- University Hospital, Bonn
See details and how to joinNCT06352216 - No phaseTaking peopleDynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
- Where
- Frankfurt am Main
- People
- 100
- Run by
- Christoph Königs
See details and how to joinNCT05802836 - No phaseTaking peopleGerman Pediatric Hemophilia Research Database
- Where
- Frankfurt am Main
- Age
- Up to 18 years
- People
- 800
- Run by
- Goethe University
See details and how to joinNCT02912143